Key result
FNDC5 overexpression alleviated high-fat diet-induced increases in serum lipids and aortic plaque area in ApoE-/- mice, likely via upregulation of PPARα/HO-1 signaling.
Why the study?
The role of fibronectin type III domain-containing protein 5 (FNDC5) in atherosclerosis development and its underlying mechanism remained to be determined.
Does FNDC5 overexpression attenuate atherosclerotic plaque formation in ApoE-/- mice?
Does FNDC5 overexpression attenuate atherosclerotic plaque formation in ApoE-/- mice?
FNDC5 overexpression attenuates atherosclerotic plaque formation in ApoE-/- mice, likely via upregulation of PPARα/HO-1 signaling.
Supports FNDC5 as atherosclerosis target in mice; leaves open human translation and clinical testing.
INTRODUCTION: This study attempted to observe the role of fibronectin type III domain-containing protein 5 (FNDC5) in atherosclerosis development and the underlying mechanism. METHODS: After being fed a high-fat diet (HFD), ApoE-/- mice were injected with saline, control adenovirus (Ad-vector), or FNDC5 overexpressing adenovirus (Ad-FNDC5). ApoE-/- mice fed with a chow diet were considered the control. After 12 weeks of treatment, the levels of serum high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and irisin were detected by commercial kits. RESULTS: Compared with the control, the serum TG, TC, and LDL-C levels, aortic plaque area, and weight were significantly increased, while serum HDL-C and irisin levels were reduced in HFD mice. Treating with Ad-FNDC5 could alleviate these changes in HFD mice and cause the activation of PPARα/HO-1 signaling in aortic tissue. After co-treating with GW6471, a PPARα antagonist, the effects of Ad-FNDC5 on the weight, serum LDL-C, TC, TG, and HDL-C levels, and aortic plaque of HFD mice were partly blocked. CONCLUSION: Elevated FNDC5 has a delaying effect on atherosclerotic plaque formation, which may be related to the upregulation of PPARα/HO-1 signaling.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2023) studied Atherosclerosis. FNDC5 overexpressing adenovirus (Ad-FNDC5) vs. Saline or control adenovirus (Ad-vector) in HFD mice, and chow diet control was evaluated on Atherosclerotic plaque formation and serum lipid levels. FNDC5 overexpression alleviated high-fat diet-induced increases in serum lipids and aortic plaque area in ApoE-/- mice, likely via upregulation of PPARα/HO-1 signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: